Vanderbilt Center for Antibody Therapeutics (VCAT)

antibodies

Diversity key in antibody repertoire

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

Aliquots – VUMC research highlights

$2.4 million NIH grant puts Children’s Hospital researcher at forefront of new direction in HIV research

After recent efforts to develop a vaccine to protect against AIDS proved ineffective, the National Institutes of Health announced a change in research direction; and it\’s one that will involve the lab of James Crowe, M.D., professor of Pediatrics, Microbiology and Immunology at the Monroe Carell Jr. Children\’s Hospital at Vanderbilt.

Senior Day Study Break Video: "Influenza: A Concern for All People (pan demos)"

James Crowe, M.D., is a Vanderbilt professor of pediatrics, microbiology and immunology. Crowe discussed the concerns associated with possible influenza pandemic.

Vanderbilt Children’s Hospital Ranks Sixth in Nation for NIH Research Funding

Moving up two places from rankings announced last year, researchers from the Department of Pediatrics at the Monroe Carell Jr. Children’s Hospital at Vanderbilt are listed as sixth in the nation for federal funding of pediatric research with grants in 2005 totaling $20,238,000.

1 11 12 13 14